Acquisition Opportunity CardioMed Device Consultants was recently acquired by Tentamus Group, signaling a potential shift in strategic priorities, access to expanded distribution, and cross-sell opportunities with Tentamus’ broader life sciences services for medical device clients.

Regulatory Expertise With deep regulatory, engineering, and clinical experience and ties to the FDA, CardioMed can be positioned as a go-to partner for manufacturers seeking faster market clearance, quality compliance programs, and streamlined device validation services.

Market Positioning Operating in the medical device consulting niche with a revenue profile in the lower mid-market segment, there is an opportunity to upsell more comprehensive end-to-end solutions akin to larger firms and to expand into adjacent regulatory testing and post-market support.

Technology & Efficiency Existing tech stack and focus on regulatory agility suggest selling digital workflow, document management, and secure data collaboration tools that enhance compliance tracking, submission readiness, and audit readiness for clients.

Growth Readiness The combination of modest staff size and high-value expertise positions CardioMed for scalable growth through strategic partnerships, white-label services, or joint ventures within Tentamus’ ecosystem to broaden service offerings and client reach.